Summary
This is a National Institutes of Health (NIH) funding opportunity announcement (FOA) for neurologic clinical trials under the SIREN (Strategies to Innovate EmeRgENcy Care Clinical Trials Network) program. The opportunity uses a UG3/UH3 phased award mechanism, where UG3 represents a milestone-driven planning phase and UH3 represents the subsequent implementation/trial phase. A clinical trial is explicitly required. The FOA is open for submissions from November 2024 through July 2026, indicating a multi-cycle announcement.